We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Anticancer Therapies – News and Features

News

Radient Pharmaceuticals Appoints Biotech Executive Dr. Leonard Reyno to its Board of Directors

Dr. Reyno replaces Minghui Jia, who resigned from the Company's Board of Directors effective August 19th, 2011.
News

Two Studies Provide Insight into Kidney Cancer

Metabolon, Inc. announces the publication of studies in two peer-reviewed journals that support the use of metabolomics in the diagnosis and treatment of kidney cancer.
News

Agennix Announces Issuance of European Patent Covering Use of Talactoferrin to Treat Cancer

The patent has a term until 2023.
News

apceth is Granted a Manufacturer's Licence for Somatic Cell Therapy

Manufacturer's licence enables contract manufacture and development of innovative cell preparations for contractual partners.
News

Nanospectra Biosciences, Inc. Names John Stroh New CEO

John Stroh replaces former CEO J. Don Payne.
News

Oncolytics Biotech® Inc. Announces Second Quarter 2011 Results

Company announces financial results and operational highlights for the quarter ended June 30, 2011.
News

Survival of Stage-4 Breast Cancer Patients Improves with Stem Cell Treatment, Study Finds

The study analyze the long-term outcomes of women who received their own stem cells that had undergone purification process.
News

First Human Trials of Anti-HIV drug Made via GM Plants

An antiviral drug synthesised by genetically modified plants is being tested on a small number of women in the UK to establish its safety, bringing closer the possibility of cheap modern medicines for the developing world.
News

Stem Cells Restore Cognitive Abilities Impaired by Brain Cancer Treatment

UCI study sheds light on how transplantation alleviates side effects of radiotherapy.
News

MagForce Nanotechnologies AG Announces Establishment of NanoTherm Therapy Treatment Center at Charité University Medical Center

The principle of the therapy is the use of nanoparticles containing iron oxide, which are injected into brain tumor in a procedure similar to a biopsy.
Advertisement